How Thermo Fisher Scientific, Merck and Horizon Discovery Group Dominate the Genome Engineering Market?

-

The global Genome Engineering Market is projected to be valued at USD 3.19 Billion in 2017 and is expected to grow at a CAGR of 14.5% to reach to USD 6.28 Billion by 2022.
Thermo Fisher Scientific (US) is the leading player in the global genome editing market. The company operates in over 50 countries across North America, Europe, Asia, and Latin America. The company’s business segments include Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Services. To maintain its position and increase its customer base in the Genome Engineering Market, the company mainly focuses on expanding its market presence by adopting growth strategies, such as acquisitions, partnerships, and collaborations. For instance, in July 2016, Thermo Fisher partnered with healthBioMed (HBM) (China) to support HBM in the development of molecular diagnostics kits. Through this partnership, HBM aimed to develop pharmacogenomics kits and support the precision medicine initiative in China. Furthermore, in March 2016, Thermo acquired Affymetrix (US) to enhance its product portfolio. Moreover, the company invests in R&D activities to increase its depth of capabilities in technologies, software, and services. It invested 5.0%, 4.08%, and 4.09% of its total revenue in 2016, 2015, and 2014, respectively in R&D activities.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000
Merck (Germany) held the second-largest in the genome editing market. The company has gained a major share in the market on account of its diversified product portfolio, widespread geographical presence, and focus on strategies such as expansions. In recent years, the company has witnessed tremendous growth in revenue in the genome editing business by pursuing the strategy of expansions to strengthen its business position in the Genome Engineering Market. For instance, in May 2016, the company expanded its viral and gene production facility in California (US) to meet the growing demand for viral and gene therapy products. The company focuses on R&D activities to develop technologically advanced products for this market. In 2016, the company invested USD 2.19 billion (13.1% of its revenue) in R&D activities.
Horizon Discovery Group (UK) is another prominent player in the Genome Engineering Market. The company is a leading supplier of genetically defined cell lines, reporter gene assay kits, genomic reference standards, and contract research services. With a diversified product portfolio, wide geographical reach, and focus on inorganic strategies such as acquisitions, collaborations, and agreements, the company has succeeded in creating a strong foothold in the Genome Engineering Market. For instance, in January 2015, Horizon Discovery acquired Haplogen Genomics GmbH, a biotechnology company based in Vienna, Austria. The acquisition provided Horizon with a cell line generation platform. It invested 25.6%, 26.3%, and 18.1% of its total revenue in 2016, 2015, and 2014, respectively in R&D activities.
Other prominent players include GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland).

Related Links: https://www.marketsandmarkets.com/ResearchInsight/genome-editing-engineering-market.asp
https://www.marketsandmarkets.com/PressReleases/genome-editing-engineering.asp

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more